FDA grants IND clearance for Servier ’s UCART19 to treat relapsed / refractory ALL

The US Food and Drug Administration (FDA) has granted an investigational new drug (IND) clearance to Servier to proceed with the clinical development of UCART19 in the country.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news